Key Performance
More- Earnings Score: 30
- Momentum Score: 27
- True Yield: N/A
- Financial Health Score: 40
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
The global facial serum market is projected to grow from US$5.0 billion in 2025 to US$7.2 billion by 2032, with a CAGR of 5.2%. Growth is driven by innovations in formulations, personalization through AI-driven skin analysis, clean beauty trends, and expansion of e-commerce channels. Anti-aging serums are expected to reach US$1.8 billion by 2032, while China is forecasted to grow at 8.1% CAGR.
05/21/2026, 4:59 AM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Coty Inc. common stock between November 5, 2025 and February 4, 2026 of the May 22, 2026 deadline to become lead plaintiffs in an ongoing securities class action. The lawsuit alleges that Coty made false or misleading statements regarding slowing growth in the beauty market, underperformance in Consumer Beauty, compressed margins from increased marketing investments, and declining growth in its Prestige fragrance segment.
05/18/2026, 7:11 PM • GlobeNewswire
A class action lawsuit has been filed against Coty, Inc. on behalf of investors who purchased stock between November 5, 2025, and February 4, 2026. The lawsuit alleges that Coty made false and misleading statements regarding slowing growth in the Consumer Beauty market, compressed margins due to increased marketing investments, and declining growth in the Prestige fragrance segment. Investors have until May 22, 2026, to apply to be appointed as lead plaintiff.
05/18/2026, 4:58 PM • GlobeNewswire
The Gross Law Firm has issued a shareholder alert for Coty Inc. (NYSE: COTY) regarding a securities class action lawsuit. The lawsuit alleges that Coty provided misleading statements about its business performance while concealing material adverse facts regarding slowing growth in Consumer Beauty and Prestige fragrance segments, compressed margins, and operational issues. Following disappointing Q2 FY2026 earnings announced on February 4-5, 2026, and CEO transition, Coty's stock declined approximately 22% from $3.43 to $2.66 per share. The company withdrew its FY2026 EBITDA guidance and revised its outlook downward.
05/15/2026, 9:00 AM • GlobeNewswire
Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Atara Biotherapeutics (ATRA), Coty Inc. (COTY), Super Micro Computer (SMCI), and ImmunityBio (IBRX). The lawsuits allege that defendants made false or misleading statements regarding their business operations and prospects. Lead plaintiff deadlines range from May 22-26, 2026.
05/14/2026, 2:45 PM • GlobeNewswire
The DJS Law Group has filed a class action lawsuit against Coty Inc. (NYSE: COTY) for securities law violations, alleging the company made false and misleading statements about its growth prospects. According to the complaint, Coty overstated growth in its Consumer Beauty segment while experiencing margin pressures from increased marketing costs. The class period runs from November 5, 2025 to February 4, 2026, with a deadline of May 22, 2026 for shareholders to join the case.
05/14/2026, 3:24 AM • Benzinga
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is seeking investors who purchased Coty Inc. securities between November 5, 2025 and February 4, 2026 to join a class action lawsuit alleging securities fraud. The firm claims Coty made false and misleading statements about its fiscal year 2026 growth prospects, while the Consumer Beauty segment was underperforming and increasing marketing spend was impacting margins.
05/14/2026, 3:20 AM • Benzinga
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm has filed a class action lawsuit against Coty Inc. for alleged violations of securities laws. The lawsuit claims Coty made false and misleading statements about its fiscal year 2026 growth prospects, while the company's growth was actually slowing and its Consumer Beauty segment was underperforming. Investors who purchased Coty securities between November 5, 2025 and February 4, 2026 are encouraged to join the case by May 22, 2026.
05/11/2026, 10:00 AM • GlobeNewswire
Rosen Law Firm is notifying investors about securities class action lawsuits filed against Power Solutions International (PSIX) and other companies. The firm is seeking a lead plaintiff for the PSIX case with a May 19, 2026 deadline. According to the lawsuit, Power Solutions made false statements about its ability to capture sales demand in the data center market and understated manufacturing capacity challenges.
05/10/2026, 7:58 PM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Coty Inc. common stock between November 5, 2025 and February 4, 2026 of an important May 22, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Coty made false and misleading statements regarding slowing growth in the beauty market, underperformance in Consumer Beauty, compressed margins, and declining Prestige fragrance segment growth.
05/10/2026, 7:44 PM • GlobeNewswire
A class action lawsuit has been filed against Coty Inc. alleging that company executives made materially false and misleading statements about growth and profitability prospects during the Class Period (November 5, 2025 - February 4, 2026). The complaint claims Coty concealed slowing growth in its Consumer Beauty segment, margin pressures from increased marketing expenditures, and decelerating growth in its Prestige fragrance segment. Investors who purchased Coty securities during this period are encouraged to join the case, with a lead plaintiff deadline of May 22, 2026.
05/10/2026, 12:00 PM • GlobeNewswire
Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Atara Biotherapeutics, Coty Inc., Super Micro Computer, and ImmunityBio. The lawsuits allege that defendants made false or misleading statements regarding their business operations and prospects. Investors have until late May 2026 to file lead plaintiff motions.
05/07/2026, 1:54 PM • GlobeNewswire
A class action lawsuit has been filed against Coty, Inc. for allegedly making false and misleading statements regarding slowing growth in the beauty market, underperformance in Consumer Beauty, compressed margins from increased marketing investments, and slowing growth in the Prestige fragrance segment. Investors who purchased Coty stock between November 5, 2025, and February 4, 2026, have until May 22, 2026, to apply as lead plaintiff.
05/05/2026, 6:27 PM • GlobeNewswire
Coty Inc. faces a securities fraud lawsuit after the company allegedly made false growth projections in November 2025, promising $1 billion in adjusted EBITDA, only to withdraw guidance three months later and report Q3 EBITDA of just $100-110 million. The stock fell 22% following corrective disclosures, with investors claiming management concealed underperformance in Prestige fragrance and Consumer Beauty segments, as well as margin compression. The lead plaintiff deadline is May 22, 2026.
05/04/2026, 9:53 PM • GlobeNewswire
Hagens Berman has launched a securities class action lawsuit against Coty Inc. for allegedly misleading investors about business trends. The lawsuit covers the period from November 5, 2025 to February 4, 2026. On February 5, 2026, Coty revealed significant operational issues including a 70% plunge in Consumer Beauty operating income and an 18% decline in Prestige operating income, while also withdrawing its FY 2026 guidance. CEO Sue Y. Nabi departed abruptly in December 2025, and Coty shares fell over 8% following the earnings announcement.
05/04/2026, 10:56 AM • GlobeNewswire
Statistics
MoreInformation as of 06/22/2026
Company Profile
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. It operates through two segments: the Prestige and Consumer Beauty. The company provides fragrance, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York. Coty Inc. is a subsidiary of JAB Beauty B.V.